Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Agile Therapeutics Inc.

    NASDAQ: AGRX · Real-Time Price · USD
    1.51
    0.05 (3.42%)
    At close: Aug 22, 2024, 9:58 PM

    Agile Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 19.59M 10.88M 4.1M
    Cost of Revenue
    		 8.98M 6.84M 10.72M
    Gross Profit
    		 10.62M 4.05M -6.62M
    Operating Income
    		 -19.88M -41.43M -71M
    Interest Income
    		 78K 80K 25K
    Pretax Income
    		 -14.46M -30.09M -74.89M
    Net Income
    		 -14.46M -25.41M -76.58M
    Selling & General & Admin
    		 28.27M 42.23M 58.14M
    Research & Development
    		 2.23M 3.25M 6.25M
    Other Expenses
    		 n/a n/a n/a
    Operating Expenses
    		 30.5M 45.48M 64.39M
    Interest Expense
    		 1.42M 3.13M 3.91M
    Selling & Marketing Expenses
    		 17.77M 30.37M 43.44M
    Cost & Expenses
    		 39.48M 52.32M 75.11M
    Income Tax Expense
    		 n/a -4.67M 1.69M
    Shares Outstanding (Basic)
    		 2.16M 432.22K 1.21K
    Shares Outstanding (Diluted)
    		 2.16M 432.22K 1.21K
    EPS (Basic)
    		 -6.71 -58.79 -63.12K
    EPS (Diluted)
    		 -6.71 -58.79 -63.12K
    EBITDA
    		 -19.88M -39.9M -64.93M
    EBIT
    		 -13.05M -26.96M -67.15M
    Depreciation & Amortization
    		 386K 1.53M 2.22M

    Add to Watchlist